Common People's Pharmacy And Baiyang Medicine To Explore Commercial Marketing Mode

Recently, Baiyang Pharmaceutical Group held a strategic cooperation signing ceremony with the theme of "strategic cohesion and win-win cooperation", and the two sides jointly announced a strategic cooperation. This is the first cooperation with the chain drugstore after the 100 billion start of the 100 billion prescription drug retail platform project. In the next 2 years, with the support of the Baiyang Pharmaceutical Group's commercial platform, the public pharmacies will be transformed from "drug retailers" to "health service providers".

In the future, the two sides will collaborate on the whole solution of prescription information sharing platform, prescription medicine plus special medicine retail supply chain, and jointly explore new categories and new marketing modes. Through the training of new technology empowerment and pharmaceutical services, the operation and management efficiency and pharmaceutical service ability of pharmacies can be improved, and the accessibility of all kinds of prescription drugs can be improved, and the progress of the industry can be promoted.

For this cooperation, Wang Li, executive director of the public pharmacy, said: "at present, Baiyang has laid out the layout of the prescription outflow and the introduction of prescription drugs, which has laid a good foundation for our future cooperation."

In recent years, China's drug retail market has maintained a growth trend under the promotion of policies, markets and capital. Data show that in 2018, the scale of China's pharmaceutical retail market was 391 billion 900 million yuan, with a growth rate of 7.5%. Although it has slowed down compared with last year, it is still higher than the overall growth rate of the terminal market and the growth rate of public hospital terminals.

The media has learned that with the landing of prescription, the practice of regulating licensed pharmacists, and the classification and management of drugstores, the pharmaceutical retail industry has also faced new challenges. Since 2017, the number of retail drugstores in China has declined, while the drugstore chain has exceeded 50%, which means that the concentration of industries is increasing and competition is becoming more intense. In response, Fu Gang, chairman of Baiyang Pharmaceutical Group, said: "Baiyang can study all links of medical institutions, retail enterprises and industrial enterprises, and help pharmaceutical companies enter advanced medical products and medical technology through high-quality retail channels to promote the transformation and upgrading of China's pharmaceutical retail enterprises."

It is reported that Baiyang, as a platform for the commercialization of medicine, provides four core values for the retail chain drugstores to undertake the prescription, the supply chain as a whole, the pharmaceutical service and the marketing innovation. It helps the drugstores optimize their own category structure, achieve passenger flow capture and resource allocation, and help the drugstore to realize professional development.